Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 53 full-time employees. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. The company is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Mr. Zackary Irani 1994 'den beri şirketle birlikte olan Biomerica Inc 'in Chief Executive Officer 'ıdır.
BMRA hissesinin fiyat performansı nasıl?
BMRA 'in mevcut fiyatı $0 'dir, son işlem günde 0% azalmış etti.
Biomerica Inc için ana iş temaları veya sektörler nelerdir?
Biomerica Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Biomerica Inc 'in piyasa değerlemesi nedir?
Biomerica Inc 'in mevcut piyasa değerlemesi $6.0M 'dir
Biomerica Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Biomerica Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 3 al, 1 tut, 0 sat ve 3 güçlü sat içermektedir